To determine if this indeed the case, we have initiated this study by determining the expression patterns of CCL2, CCL5, TNFα and IL-1β in biopsy sections of healthy individuals and in breast cancer patients at different progression stages of disease. This evidence concerns the gene CCL5 and breast cancer.